Frequency of Thrombocytopenia and Fetomaternal Outcome in Pregnant Women Presenting at Sahiwal Teaching Hospital, Sahiwal
Keywords:
Thrombocytopenia, Pregnancy, Platelet count, Fetomaternal outcome, Gestational age, Postpartum hemorrhageAbstract
The global escalation of multidrug-resistant (MDR) Gram-negative bacterial infections has intensified the demand for novel and sustainable antimicrobial strategies. Silver-nanoparticles
Background:If thrombocytopenia is not identified and treated quickly, it can harm the health of the mother and the unborn child. It is the second most prevalent hematological condition during pregnancy after anemia.
Objective: To find out the prevalence of thrombocytopenia and related fetal outcomes in pregnant mothers.
Methods:The study involved 161 pregnant women in their third trimester (≥28 weeks of gestation) who were hospitalized to the Department of Obstetrics and Gynecology at Sahiwal Teaching Hospital, Sahiwal, as part of a descriptive case series that lasted six months, from 1, October 2024, to 31, March, 2025. Sequential sampling with non-probability was employed. With the aid of SPSS version 25.0, information on fetal outcomes, platelet counts, and maternal demographics was gathered and examined. A p-value of less than 0.05 was deemed significant, and associations were evaluated using the chi-square test.
Results:
The frequency of thrombocytopenia was 16.1%. Among thrombocytopenic women, postpartum hemorrhage (26.9%) and low Apgar scores at 1 minute (23.1%) were the most common complications, followed by neonatal jaundice (19.2%) and NICU admissions (15.4%). A significant association was found between gestational age <36 weeks and thrombocytopenia (p = 0.022). Other variables, including age, parity, residence, and income, were not statistically significant.
Conclusion:
Thrombocytopenia is relatively common in third-trimester pregnancies and is associated with adverse fetomaternal outcomes, particularly when occurring before 36 weeks of gestation. Routine antenatal screening for platelet count is recommended to allow timely diagnosis and appropriate management to reduce maternal and neonatal complications.
